⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1271660 | 0.84 | LMNA (0.35) | — | |
| SCHEMBL9536133 | 0.80 | LMNA (0.41) | — | |
| SCHEMBL11348663 | 0.77 | — | — | |
| SCHEMBL9538283 | 0.77 | LMNA (0.47) | — | |
| SCHEMBL38665316 | 0.77 | LMNA (0.47) | — | |
| SCHEMBL1270539 | 0.76 | — | — | |
| SCHEMBL18241940 | 0.74 | — | — | |
| SCHEMBL13024649 | 0.74 | — | — | |
| SCHEMBL9537525 | 0.74 | LMNA (0.35) | — | |
| SCHEMBL18378072 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103505416-B | A kind of oxygen carrying fluorocarbon emulsion and preparation method thereof | 上海纳米技术及应用国家工程研究中心有限公司 | 2016-06-15 | — | — | CN | claimed |
| CN-102988294-B | Preparation method of fluorocarbon compound liposome | SH NAT ENG RES CT NANOTECH CO | 2015-03-11 | — | — | CN | claimed |
| CN-103505416-A | Oxygen-carrying fluorocarbon emulsion and preparation method thereof | SH NAT ENG RES CT NANOTECH CO | 2014-01-15 | — | — | CN | claimed |
| CN-103505419-A | Oxygen-carrying lipidosome with low surface tension and preparation method thereof | SH NAT ENG RES CT NANOTECH CO | 2014-01-15 | — | — | CN | claimed |
| CN-102988294-A | Preparation method of fluorocarbon compound liposome | SH NAT ENG RES CT NANOTECH CO | 2013-03-27 | — | — | CN | claimed |
| US-20050256211-A9 | Patient oxygenation using stabilized fluorocarbon emulsions | PFC THERAPEUTICS, LLC | 2005-11-17 | — | — | US | claimed |
| US-20040068020-A1 | Patient oxygenation using stabilized fluorocarbon emulsions | WEERS JEFFRY GREG (US) | 2004-04-08 | — | — | US | claimed |
| US-20020065326-A1 | Patient oxygenation using stabilized fluorocarbon emulsions | WEERS JEFFRY GREG (US) | 2002-05-30 | — | — | US | claimed |
| US-5914352-A | Methods for the use of stabilized fluorocarbon emulsions | ALLIANCE PHARMACEUTICAL CORP. (US) | 1999-06-22 | — | — | US | claimed |
| US-5628930-A | STORAGE STABILITY | ALLIANCE PHARMACEUTICAL CORP. (US) | 1997-05-13 | — | — | US | claimed |
| EP-0666736-B1 | STABILIZATION OF FLUOROCARBON EMULSIONS | ALLIANCE PHARMA (US) | 1996-12-18 | — | — | EP | claimed |
| EP-0666736-A1 | STABILIZATION OF FLUOROCARBON EMULSIONS. | ALLIANCE PHARMA (US) | 1995-08-16 | — | — | EP | claimed |
| WO-1994009625-A2 | STABILIZATION OF FLUOROCARBON EMULSIONS | ALLIANCE PHARMACEUTICAL CORP. (US) | 1994-05-11 | — | — | WO | claimed |
| US-5295953-A | Method and apparatus for extracorporeal separation of fluorochemicals from whole blood of a patient | HEMAGEN/PFC (US) | 1994-03-22 | — | — | US | claimed |
| WO-1993024158-A1 | METHOD AND APPARATUS FOR EXTRACORPOREAL SEPARATION OF FLUOROCHEMICALS FROM WHOLE BLOOD OF A PATIENT | HEMAGEN/PFC (US) | 1993-12-09 | — | — | WO | claimed |
| EP-0138969-A1 | METHOD FOR INHIBITING THE GROWTH OF ANAEROBES | UNIVERSITY PATENTS, INC. (US) | 1985-05-02 | — | — | EP | claimed |
| WO-1984003624-A1 | METHOD FOR INHIBITING THE GROWTH OF ANAEROBES | UNIVERSITY PATENTS INC (US) | 1984-09-27 | — | — | WO | claimed |
| US-4187252-A | NONADECAFLUORO- OR EICOSAFLUORO-2,2,4,4-TETRAMETHYLPENTANE | SUNTECH, INC. (US) | 1980-02-05 | — | — | US | claimed |
| US-4110474-A | PERFLUORO-2,2,4,4-TETRAMETHYLPENTANE, 3-HYDRO-NONADECAFLUORO-2,2,4,4-TETRAMETHYLPENTANE | SUNTECH, INC. (US) | 1978-08-29 | — | — | US | claimed |
| WO-2026106498-A1 | PERFUSION FLUID, METHODS OF PRODUCING PERFUSION FLUID, AND ITS USES | NanoSanguis S.A. (PL) | 2026-05-21 | — | — | WO | disclosed |
| US-12612714-B2 | Systems and methods for transfer of reagents between droplets | 10X GENOMICS, INC. (US) | 2026-04-28 | — | — | US | disclosed |
| US-20260009162-A1 | SYSTEMS AND METHODS FOR TRANSFER OF REAGENTS BETWEEN DROPLETS | 10X GENOMICS, INC. | 2026-01-08 | — | — | US | disclosed |
| WO-2024182243-A1 | SIGNAL BOOST ASSAY PERFORMED IN DROPLETS | VEDABIO, INC. (US) | 2024-09-06 | — | — | WO | disclosed |
| US-20240287623-A1 | SIGNAL BOOST ASSAY PERFORMED IN DROPLETS | VEDABIO, INC. | 2024-08-29 | — | — | US | disclosed |
| US-20230099063-A1 | SELF-HEALING CROSS-LINKABLE SHELLS | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2023-03-30 | — | — | US | disclosed |
| EP-3536396-B1 | FLUOROCARBON EMULSION STABILIZING SURFACTANTS | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-03-30 | — | — | EP | disclosed |
| US-20210381007-A1 | METHODS AND COMPOSITIONS FOR CRISPR EDITING OF CELLS AND CORRELATING THE EDITS TO A RESULTING CELLULAR NUCLEIC ACID PROFILE | INSCRIPTA, INC. | 2021-12-09 | — | — | US | disclosed |
| US-20210332388-A1 | COMPOSITIONS, METHODS, MODULES AND INSTRUMENTS FOR AUTOMATED NUCLEIC ACID-GUIDED NUCLEASE EDITING IN MAMMALIAN CELLS | INSCRIPTA, INC. | 2021-10-28 | — | — | US | disclosed |
| EP-3787687-A1 | SELF-HEALING CROSS-LINKABLE SHELLS | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2021-03-10 | — | — | EP | disclosed |
| US-10590381-B2 | Composition for collecting and preserving placental stem cells and methods of using the composition | Celularity, Inc. (US) | 2020-03-17 | — | — | US | disclosed |
| EP-3563871-A1 | SELF-HEALING CROSS-LINKABLE SHELLS | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2019-11-06 | — | — | EP | disclosed |
| EP-3536396-A1 | FLUOROCARBON EMULSION STABILIZING SURFACTANTS | The President and Fellows of Harvard College (US) | 2019-09-11 | — | — | EP | disclosed |
| EP-2077912-B1 | FLUOROCARBON EMULSION STABILIZING SURFACTANTS | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2019-03-27 | — | — | EP | disclosed |
| US-20170327788-A1 | COMPOSITION FOR COLLECTING AND PRESERVING PLACENTAL STEM CELLS AND METHODS OF USING THE COMPOSITION | ANTHROGENESIS CORPORATION (US) | 2017-11-16 | — | — | US | disclosed |
| US-9725694-B2 | Composition for collecting and preserving placental stem cells and methods of using the composition | ANTHROGENESIS CORPORATION (US) | 2017-08-08 | — | — | US | disclosed |
| US-9598669-B2 | Composition for collecting placental stem cells and methods of using the composition | ANTHROGENESIS CORPORATION (US) | 2017-03-21 | — | — | US | disclosed |
| US-9498761-B2 | Fluorocarbon emulsion stabilizing surfactants | RAINDANCE TECHNOLOGIES, INC. (US) | 2016-11-22 | — | — | US | disclosed |
| CN-103505416-B | A kind of oxygen carrying fluorocarbon emulsion and preparation method thereof | 上海纳米技术及应用国家工程研究中心有限公司 | 2016-06-15 | — | — | CN | disclosed |
| CN-103505419-B | Oxygen carrier liposome of a kind of low surface tension and preparation method thereof | Shanghai National Engineering Research Center for Nanotechnology Co., Ltd. (CN) | 2016-01-13 | — | — | CN | disclosed |
| US-20150217246-A1 | FLUOROCARBON EMULSION STABILIZING SURFACTANTS | BIO-RAD LABORATORIES, INC. | 2015-08-06 | — | — | US | disclosed |
| US-9012390-B2 | Fluorocarbon emulsion stabilizing surfactants | RAINDANCE TECHNOLOGIES, INC. (US) | 2015-04-21 | — | — | US | disclosed |
| CN-102988294-B | Preparation method of fluorocarbon compound liposome | SH NAT ENG RES CT NANOTECH CO | 2015-03-11 | — | — | CN | disclosed |
| US-8748497-B2 | Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses | ALLIANCE PHARMACEUTICAL CORP. (US) | 2014-06-10 | — | — | US | disclosed |
| CN-103505419-A | Oxygen-carrying lipidosome with low surface tension and preparation method thereof | SH NAT ENG RES CT NANOTECH CO | 2014-01-15 | — | — | CN | disclosed |
| CN-103505416-A | Oxygen-carrying fluorocarbon emulsion and preparation method thereof | SH NAT ENG RES CT NANOTECH CO | 2014-01-15 | — | — | CN | disclosed |
| US-20100298445-A1 | Optimized Fluorocarbon Emulsions for Blood Substitutes and Other Therapeutic Uses | ALLIANCE PHARMACEUTICAL CORP | 2010-11-25 | — | — | US | disclosed |
| US-20100291679-A1 | COMPOSITION FOR COLLECTING AND PRESERVING PLACENTAL STEM CELLS AND METHODS OF USING THE COMPOSITION | ANTHROGENESIS CORPORATION | 2010-11-18 | — | — | US | disclosed |
| US-20100105112-A1 | FLUOROCARBON EMULSION STABILIZING SURFACTANTS | BIO-RAD LABORATORIES, INC. | 2010-04-29 | — | — | US | disclosed |
| EP-2034959-A2 | OPTIMIZED FLUOROCARBON EMULSIONS FOR BLOOD SUBSTITUTES AND OTHER THERAPEUTIC USES | Alliance Pharmaceutical Corp (US) | 2009-03-18 | — | — | EP | disclosed |
| EP-1755617-A4 | PERFLUOROCARBON-SOLUBLE COMPOUNDS | UNIV SOUTHERN CALIFORNIA (US) | 2009-02-25 | — | — | EP | disclosed |
| EP-1974013-A2 | IMPROVED COMPOSITION FOR COLLECTING AND PRESERVING PLACENTAL STEM CELLS AND METHODS OF USING THE COMPOSITION | Anthrogenesis Corporation (US) | 2008-10-01 | — | — | EP | disclosed |
| WO-2007139827-A2 | OPTIMIZED FLUOROCARBON EMULSIONS FOR BLOOD SUBSTITUTES AND OTHER THERAPEUTIC USES | ALLIANCE PHARMACEUTICAL CORP. (US) | 2007-12-06 | — | — | WO | disclosed |
| US-20070190042-A1 | Composition for collecting and preserving placental stem cells and methods of using the composition | Celularity, Inc. | 2007-08-16 | — | — | US | disclosed |
| WO-2007079185-A2 | IMPROVED COMPOSITION FOR COLLECTING AND PRESERVING PLACENTAL STEM CELLS AND METHODS OF USING THE COMPOSITION | ANTHROGENESIS CORPORATION (US) | 2007-07-12 | — | — | WO | disclosed |
| EP-1755617-A1 | PERFLUOROCARBON-SOLUBLE COMPOUNDS | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2007-02-28 | — | — | EP | disclosed |
| US-20060002881-A1 | Perfluorocarbon-soluble compounds | NATIONAL SCIENCE FOUNDATION | 2006-01-05 | — | — | US | disclosed |
| US-20050256211-A9 | Patient oxygenation using stabilized fluorocarbon emulsions | PFC THERAPEUTICS, LLC | 2005-11-17 | — | — | US | disclosed |
| WO-2005107764-A1 | PERFLUOROCARBON-SOLUBLE COMPOUNDS | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2005-11-17 | — | — | WO | disclosed |
| US-20040068020-A1 | Patient oxygenation using stabilized fluorocarbon emulsions | WEERS JEFFRY GREG (US) | 2004-04-08 | — | — | US | disclosed |
| US-20020065326-A1 | Patient oxygenation using stabilized fluorocarbon emulsions | WEERS JEFFRY GREG (US) | 2002-05-30 | — | — | US | disclosed |
| US-20010019710-A1 | Contrast agents | NYCOMED IMAGING AS | 2001-09-06 | — | — | US | disclosed |
| CN-1066963-C | Contrast agents and improvements thereof | YCOMED IMAGING AS (NO) | 2001-06-13 | — | — | CN | disclosed |
| US-6204296-B1 | INTRAVENOUSLY ADMINISTERING TO SAID PATIENT A FLUOROCARBON EMULSION COMPRISING AN EMULSIFYING AGENT, PERFLUOROOCTYL BROMIDE AND PERFLUORODECYL BROMIDE. | ALLIANCE PHARMACEUTICAL CORP. | 2001-03-20 | — | — | US | disclosed |
| EP-0625068-B1 | HIGHLY FLUORINATED, CHLORO-SUBSTITUTED ORGANIC COMPOUND-CONTAINING EMULSIONS AND METHODS OF MAKING AND USING THEM | HEMAGEN PFC (US) | 2000-10-11 | — | — | EP | disclosed |
| EP-0689461-B1 | IMPROVEMENTS IN OR RELATING TO CONTRAST AGENTS | NYCOMED IMAGING AS (NO) | 2000-07-05 | — | — | EP | disclosed |
| EP-0689422-B1 | FLUOROCARBON EMULSIONS WITH REDUCED PULMONARY GAS-TRAPPING PROPERTIES | ALLIANCE PHARMA (US) | 1999-07-14 | — | — | EP | disclosed |
| US-5914352-A | Methods for the use of stabilized fluorocarbon emulsions | ALLIANCE PHARMACEUTICAL CORP. (US) | 1999-06-22 | — | — | US | disclosed |
| CN-1042794-C | Improved emulsions of highly fluorinated organic compounds | HEMAGEN PEC (US) | 1999-04-07 | — | — | CN | disclosed |
| EP-0759742-B1 | PHYSIOLOGICALLY ACCEPTABLE EMULSIONS CONTAINING PERFLUOROCARBON ETHER HYDRIDES AND METHODS OF USE | MINNESOTA MINING & MFG (US) | 1998-10-28 | — | — | EP | disclosed |
| US-5785950-A | PERFLUOROBIS(CHLOROBUTYL ETHER; MEDICAL IMAGING | HEMAGEN/PFC (US) | 1998-07-28 | — | — | US | disclosed |
| US-5684050-A | Stable emulsions of highly fluorinated organic compounds | HEMAGEN/PFC (US) | 1997-11-04 | — | — | US | disclosed |
| US-5635539-A | Stable emulsions of highly fluorinated organic compounds | HEMAGEN/PFC (US) | 1997-06-03 | — | — | US | disclosed |
| US-5635538-A | AQUEOUS PHASE, EMULSIFYING AGENT, AND LIQUID FLUOROCARBON PHASE CONTAINING MIXTURE OF AT LEAST TWO FLUOROCARBONS, AT LEAST ONE FLUOROCARBON HAS COVALENTLY ATTACHED LIPOPHILIC MOIETY | ALLIANCE PHARMACEUTICAL CORP. (US) | 1997-06-03 | — | — | US | disclosed |
| US-5628930-A | STORAGE STABILITY | ALLIANCE PHARMACEUTICAL CORP. (US) | 1997-05-13 | — | — | US | disclosed |
| EP-0642364-B1 | APPARATUS FOR EXTRACORPOREAL SEPARATION OF FLUOROCHEMICALS FROM WHOLE BLOOD OF A PATIENT | HEMAGEN PFC (US) | 1997-03-19 | — | — | EP | disclosed |
| EP-0759934-A1 | NEUROTENSIN ANTAGONIST PEPTIDES | Aventis Pharma S.A. (FR) | 1997-03-05 | — | — | EP | disclosed |
| EP-0759742-A1 | PHYSIOLOGICALLY ACCEPTABLE EMULSIONS CONTAINING PERFLUOROCARBON ETHER HYDRIDES AND METHODS OF USE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-03-05 | — | — | EP | disclosed |
| EP-0666736-B1 | STABILIZATION OF FLUOROCARBON EMULSIONS | ALLIANCE PHARMA (US) | 1996-12-18 | — | — | EP | disclosed |
| US-5567765-A | ARTIFICIAL BLOOD, CONTRAST AGENT, ORGAN PRESERVATIVE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-10-22 | — | — | US | disclosed |
| US-5514720-A | Stable emulsions of highly fluorinated organic compounds | HEMAGEN/PFC (US) | 1996-05-07 | — | — | US | disclosed |
| CN-1121315-A | Improvements in or relating to contrast agents | YCOMED IMAGING AS (NO) | 1996-04-24 | — | — | CN | disclosed |
| US-5502094-A | ARTIFICIAL BLOOD, CONTRAST AGENTS FOR MEDICAL IMAGING | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-03-26 | — | — | US | disclosed |
| EP-0689422-A1 | FLUOROCARBON EMULSIONS WITH REDUCED PULMONARY GAS-TRAPPING PROPERTIES | ALLIANCE PHARMACEUTICAL CORPORATION (US) | 1996-01-03 | — | — | EP | disclosed |
| EP-0689461-A1 | IMPROVEMENTS IN OR RELATING TO CONTRAST AGENTS | NYCOMED IMAGING AS (NO) | 1996-01-03 | — | — | EP | disclosed |
| WO-1995032218-A1 | NEUROTENSIN ANTAGONIST PEPTIDES | RHONE-POULENC RORER S.A. (FR) | 1995-11-30 | — | — | WO | disclosed |
| WO-1995031965-A1 | PHYSIOLOGICALLY ACCEPTABLE EMULSIONS CONTAINING PERFLUOROCARBON ETHER HYDRIDES AND METHODS OF USE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-11-30 | — | — | WO | disclosed |
| EP-0666736-A1 | STABILIZATION OF FLUOROCARBON EMULSIONS. | ALLIANCE PHARMA (US) | 1995-08-16 | — | — | EP | disclosed |
| US-5407962-A | Comprising surfactant and oil; shelf life, serum stability | HEMAGEN/PFC (US) | 1995-04-18 | — | — | US | disclosed |
| US-5403575-A | Acyclic di(or more)-chloroperfluoro-compounds for contrast in medical imaging, artificial blood, treatment of cardiovascular disorders | HEMAGEN/PFC (US) | 1995-04-04 | — | — | US | disclosed |
| EP-0625068-A1 | HIGHLY FLUORINATED, CHLORO-SUBSTITUTED ORGANIC COMPOUND-CONTAINING EMULSIONS AND METHODS OF MAKING AND USING THEM | HEMAGEN/PFC (US) | 1994-11-23 | — | — | EP | disclosed |
| EP-0449825-B1 | IMPROVED EMULSIONS OF HIGHLY FLUORINATED ORGANIC COMPOUNDS | HEMAGEN PFC (US) | 1994-10-19 | — | — | EP | disclosed |
| WO-1994021227-A1 | FLUOROCARBON EMULSIONS WITH REDUCED PULMONARY GAS-TRAPPING PROPERTIES | ALLIANCE PHARMACEUTICAL CORP. (US) | 1994-09-29 | — | — | WO | disclosed |
| WO-1994021301-A1 | IMPROVEMENTS IN OR RELATING TO CONTRAST AGENTS | HOLMES, MICHAEL, JOHN (GB) | 1994-09-29 | — | — | WO | disclosed |
| US-5350571-A | Contrast agents for images in medical diagnosis | HEMAGEN/PFC (US) | 1994-09-27 | — | — | US | disclosed |
| WO-1994009625-A2 | STABILIZATION OF FLUOROCARBON EMULSIONS | ALLIANCE PHARMACEUTICAL CORP. (US) | 1994-05-11 | — | — | WO | disclosed |
| US-5295953-A | Method and apparatus for extracorporeal separation of fluorochemicals from whole blood of a patient | HEMAGEN/PFC (US) | 1994-03-22 | — | — | US | disclosed |
| WO-1993024158-A1 | METHOD AND APPARATUS FOR EXTRACORPOREAL SEPARATION OF FLUOROCHEMICALS FROM WHOLE BLOOD OF A PATIENT | HEMAGEN/PFC (US) | 1993-12-09 | — | — | WO | disclosed |
| WO-1993011868-A1 | HIGHLY FLUORINATED, CHLORO-SUBSTITUTED ORGANIC COMPOUND-CONTAINING EMULSIONS AND METHODS OF MAKING AND USING THEM | HEMAGEN/PFC (US) | 1993-06-24 | — | — | WO | disclosed |
| EP-0231091-B1 | STABLE EMULSIONS OF HIGHLY FLUORINATED ORGANIC COMPOUND | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1993-03-31 | — | — | EP | disclosed |
| US-5171755-A | Containing water insoluble oil, surfactant; red blood cell substitutes, treating cardiovascular disorders | HEMAGEN/PFC (US) | 1992-12-15 | — | — | US | disclosed |
| EP-0449825-A1 | IMPROVED EMULSIONS OF HIGHLY FLUORINATED ORGANIC COMPOUNDS. | HEMAGEN PFC (US) | 1991-10-09 | — | — | EP | disclosed |
| CN-1038022-A | The improvement Emulsion of highly fluorinated organic compounds | HEMAGEN PFC (US) | 1989-12-20 | — | — | CN | disclosed |
| WO-1989010118-A1 | IMPROVED EMULSIONS OF HIGHLY FLUORINATED ORGANIC COMPOUNDS | HEMAGEN/PFC (US) | 1989-11-02 | — | — | WO | disclosed |
| CN-87100492-A | STABLE EMULSIONS OF HIGHLY FLUORINATED ORGANIC COMPOUNDS | — | 1987-08-19 | — | — | CN | disclosed |
| EP-0231091-A1 | Stable emulsions of highly fluorinated organic compound | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1987-08-05 | — | — | EP | disclosed |
| EP-0138969-A1 | METHOD FOR INHIBITING THE GROWTH OF ANAEROBES | UNIVERSITY PATENTS, INC. (US) | 1985-05-02 | — | — | EP | disclosed |
| WO-1984003624-A1 | METHOD FOR INHIBITING THE GROWTH OF ANAEROBES | UNIVERSITY PATENTS INC (US) | 1984-09-27 | — | — | WO | disclosed |
| US-4187252-A | NONADECAFLUORO- OR EICOSAFLUORO-2,2,4,4-TETRAMETHYLPENTANE | SUNTECH, INC. (US) | 1980-02-05 | — | — | US | disclosed |
| US-4110474-A | PERFLUORO-2,2,4,4-TETRAMETHYLPENTANE, 3-HYDRO-NONADECAFLUORO-2,2,4,4-TETRAMETHYLPENTANE | SUNTECH, INC. (US) | 1978-08-29 | — | — | US | disclosed |
| US-4110474-A | PERFLUORO-2,2,4,4-TETRAMETHYLPENTANE, 3-HYDRO-NONADECAFLUORO-2,2,4,4-TETRAMETHYLPENTANE | SUNTECH, INC. (US) | 1978-08-29 | — | — | US | disclosed |